Skip to Main Content

Author Details

Ming-Sound Tsao
University Health Network, University of Toronto
1972
652
112
PMIDPaper TitleJournal TitlePublished Year
37972928Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization Study.Mod Pathol2024
37717856Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment.J Thorac Oncol2024
36305267The NRF2 antagonist ML385 inhibits PI3K-mTOR signaling and growth of lung squamous cell carcinoma cells.Cancer Med2023
37633678Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies.Lancet Public Health2023
37490292Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial.JAMA Netw Open2023
37744308Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With <i>MET</i> Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies.JTO Clin Res Rep2023
37931632Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.Lancet2023
36950276Direct GDP-KRAS<sup>G12C</sup> inhibitors and mechanisms of resistance: the tip of the iceberg.Ther Adv Med Oncol2023
37185415Consensus Recommendations to Optimize the Detection and Reporting of <i>NTRK</i> Gene Fusions by RNA-Based Next-Generation Sequencing.Curr Oncol2023
37438216Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio Data.Clin Lung Cancer2023
36586421CANTRK: A Canadian Ring Study to Optimize Detection of NTRK Gene Fusions by Next-Generation RNA Sequencing.J Mol Diagn2023
36651498Wide-field Stokes polarimetric microscopy for second harmonic generation imaging.J Biophotonics2023
36841541Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171).J Thorac Oncol2023
36535627Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model.J Thorac Oncol2023
36503176Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth: A Proposal by the International Association for the Study of Lung Cancer Pathology Committee.J Thorac Oncol2023
36930839Using Recurrent Neural Networks to Extract High-Quality Information From Lung Cancer Screening Computerized Tomography Reports for Inter-Radiologist Audit and Feedback Quality Improvement.JCO Clin Cancer Inform2023
36214668Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non-Small Cell Lung Cancer.Mol Cancer Res2023
34648945Lung Cancer Driven by BRAF<sup>G469V</sup> Mutation Is Targetable by EGFR Kinase Inhibitors.J Thorac Oncol2022
35383171Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes.Nat Commun2022
35378690Integrin α11β1 in tumor fibrosis: more than just another cancer-associated fibroblast biomarker?J Cell Commun Signal2022
35595168Proteomic Characterization of a Candidate Polygenic Driver of Metabolism in Non-small Cell Lung Cancer.J Mol Biol2022
36439025Optimizing Drug Response Study Design in Patient-Derived Tumor Xenografts.Cancer Inform2022
36425756Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction.iScience2022
36456811Unsupervised determination of lung tumor margin with widefield polarimetric second-harmonic generation microscopy.Sci Rep2022
35907387PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLC.Lung Cancer2022
36233024Collagen Type XI Inhibits Lung Cancer-Associated Fibroblast Functions and Restrains the Integrin Binding Site Availability on Collagen Type I Matrix.Int J Mol Sci2022
360312952021 WHO Classification of Lung Cancer: A Globally Applicable and Molecular Biomarker-Relevant Classification.J Thorac Oncol2022
36158638Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy.Ther Adv Med Oncol2022
35978831Digital quantitative tissue image analysis of hypoxia in resected pancreatic ductal adenocarcinomas.Front Oncol2022
36184066Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee.J Thorac Oncol2022
35877212Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer.Curr Oncol2022
35278845Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare system.Cancer Treat Res Commun2022
35216726Reprint of "Introduction to 2021 WHO Classification of Thoracic Tumors".J Thorac Oncol2022
35026477The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification.J Thorac Oncol2022
34930611Introduction to 2021 WHO Classification of Thoracic Tumors.J Thorac Oncol2022
35165102Targeting the Ubiquitin-Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer.Clin Cancer Res2022
34808341The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.J Thorac Oncol2022
34800700CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLC.J Thorac Oncol2022
32924180Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer.Genet Epidemiol2021
33771657The International Association for the Study of Lung Cancer Molecular Database Project: Objectives, Challenges, and Opportunities.J Thorac Oncol2021
33718025Prognostic and predictive effect of <i>KRAS</i> gene copy number and mutation status in early stage non-small cell lung cancer patients.Transl Lung Cancer Res2021
33515487Early innate and adaptive immune perturbations determine long-term severity of chronic virus and Mycobacterium tuberculosis coinfection.Immunity2021
33667493Risk Perception Among a Lung Cancer Screening Population.Chest2021
33662578The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC.J Thorac Oncol2021
33582070Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint Inhibitors.Clin Lung Cancer2021
33580222PD-L1 as a biomarker of response to immune-checkpoint inhibitors.Nat Rev Clin Oncol2021
33775406The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis.Pathology2021
33915250Prevalence and Heterogeneity of PD-L1 Expression by 22C3 Assay in Routine Population-Based and Reflexive Clinical Testing in Lung Cancer.J Thorac Oncol2021
34917991Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy.JTO Clin Res Rep2021
35008369Tumor-Associated Regulatory T Cell Expression of LAIR2 Is Prognostic in Lung Adenocarcinoma.Cancers (Basel)2021
  • 1 - 50 of 652

Recommended Authors

Majd Al Assaad
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2018
Number of shared co-authors 0
Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
Yisong Wang
Lombardi Comprehensive Cancer Center, Georgetown University
Career Start Year 2010
Number of shared co-authors 2
Chad V Pecot
University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 15
Wei Zhang
Montefiore Medical Center
Career Start Year 2008
Number of shared co-authors 8
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year 2008
Number of shared co-authors 1
Iacopo Petrini
University of Pisa
Career Start Year 2006
Number of shared co-authors 3
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 11
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 10
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 29
Kristopher K Frese
Cancer Research UK Manchester Institute, University of Manchester
Career Start Year 2003
Number of shared co-authors 3
Trever G Bivona
University of California san francisco
Career Start Year 2002
Number of shared co-authors 17
Eric A Collisson
University of California san francisco
Career Start Year 1999
Number of shared co-authors 25
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 1
Collin M Blakely
University of California san francisco
Career Start Year 1998
Number of shared co-authors 7
Patrick Micke
Uppsala University
Career Start Year 1997
Number of shared co-authors 1
Jorge Nieva
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year 1995
Number of shared co-authors 3
Michael Peyton
Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center
Career Start Year 1994
Number of shared co-authors 19
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 1
Pierre P Massion
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1993
Number of shared co-authors 26
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 23
David N Watkins
Research Institute in Oncology and Hematology
Career Start Year 1991
Number of shared co-authors 17
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 12
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 31
David S Schrump
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 6
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 31
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 3
Cuong Hoang-Vu
Center for Cancer Research, National Cancer Institute
Career Start Year 1985
Number of shared co-authors 3
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 26
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 18

Collaborators

Frances A Shepherd
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 153
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers 95
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 56
Chang-Qi Zhu
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 47
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 40
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 38
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Co-authored papers 37
Igor Jurisica
Schroeder Arthritis Institute
Co-authored papers 33
Michael R Johnston
Dalhousie University
Co-authored papers 32
Andrew G Nicholson
Co-authored papers 32
Ming Li
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 28
Roya Navab
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 27
Thomas K Waddell
Toronto General Hospital
Co-authored papers 23
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Co-authored papers 22
Shaf Keshavjee
University Health Network, University Health Network and University of Toronto
Co-authored papers 21
Wan L Lam
British Columbia Cancer Research Institute
Co-authored papers 20
David W Hedley
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 20
Keyue Ding
Queen's University
Co-authored papers 18
Gail Darling
University of Toronto
Co-authored papers 18
Nadeem Moghal
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 17
Michael F Moran
Hospital for Sick Children, University of Toronto
Co-authored papers 17
Sandy D Der
Toronto General Research Institute, University Health Network
Co-authored papers 17
Jeremy A Squire
University of Sao Paulo
Co-authored papers 16
Wei Xu
Princess Margaret Cancer Centre
Co-authored papers 14
Alain C Borczuk
Co-authored papers 14
Rayjean J Hung
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 14
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 14
Zhuo Chen
The First Hospital of Lanzhou University
Co-authored papers 14
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Co-authored papers 14
John K Field
University of Liverpool, Molecular & Clinical Cancer Medicine
Co-authored papers 13
Release 1.2